KALTF
Kalytera Therapeutics Inc

129
Mkt Cap
$1.13M
Volume
25.00
52W High
$0.0001
52W Low
$0.00
50D MA
$0.00
KALTF Fundamentals
Beta
2,149.13
Avg. Volume
28.57
Loading...
Loading...
Claritas Pharmaceuticals, Inc. engages in the development of next generation cannabinoid therapeutics. It also offers development programs for bone fracture healing, osteogenesis imperfecta, osteoporosis, and osteoporosis in Prader-Willi syndrome. The company was founded by Seth Yakatan on October 15, 2004 and is headquartered in San Rafael, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Claritas Pharmaceuticals Inc?
What is the 52-week high for Claritas Pharmaceuticals Inc?
What is the 52-week low for Claritas Pharmaceuticals Inc?
What is the 50-day moving average of Claritas Pharmaceuticals Inc?

Latest KALTF News

View
No KALTF news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.